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We provide a detailed characteristic of stem cells isolated and expanded from the human dental pulp. Dental pulp stem cells
express mesenchymal cell markers STRO-1, vimentin, CD29, CD44, CD73, CD90, CD166, and stem cell markers Sox2, nestin, and
nucleostemin. They are multipotent as shown by their osteogenic and chondrogenic potential. We measured relative telomere
length in 11 dental pulp stem cell lines at diﬀerent passages by quantitative real-time PCR. Despite their large proliferative
capacity,stableviability,phenotype,andgenotypeoverprolongedcultivation,humandentalpulpstemcellssuﬀerfromprogressive
telomere shortening over time they replicate in vitro. Relative telomere length (T/S) was inversely correlated with cumulative
doubling time. Our ﬁndings indicate that excessive ex vivo expansion of adult stem cells should be reduced at minimum to avoid
detrimental eﬀects on telomere maintenance and measurement of telomere length should become a standard when certiﬁcating
the status and replicative age of stem cells prior therapeutic applications.
1.Introduction
Within adult multicellular organisms populations of stem
cellsareresponsiblefortissuemaintenanceandregeneration.
Since these primitive cells are endowed with unique bio-
logical properties like unlimited self-renewal, extensive pro-
liferative capacity, and broad diﬀerentiation potential, they
represent a promising tool for cell replacement strategies in
treatment of degenerating and ageing tissues. Stem cells have
been identiﬁed in most tissues of both developing (e.g., [1–
3]) and adult organisms (e.g., [4–6] ) .T h ed e n t a lp u l pi sn o
exception. The dental pulp is well-delineated compartment
with connective tissue that structurally resembles primitive
connective tissues. Few studies gave evidence that this tissue
contains a special population of adult stem cells [7–9].
These studies characterized dental pulp stem cells (DPSCs)
cultured under diﬀerent in vitro conditions and reported
some similarity to bone marrow mesenchymal stem cells,
for example, in expression of mesenchymal markers as well
as diﬀerences in some biological properties such as distinct
growth kinetics and capacity to restore dental structures.
In order to perform their vital functions until old age,
stem cells are endowed with diverse mechanisms contribut-
ingtostemcellsresistanceandlongevity.Forexample,asym-
metric division [10] prevents stem cell exhaustion. In tissues,
stem cells are placed in a protective microenvironment2 Journal of Biomedicine and Biotechnology
(niche). Moreover, stem cells have lower reactive oxygen
species levels than somatic cells [11] and also have multi-
ple speciﬁc molecular mechanisms [12] including proteins
of detoxiﬁer system, which provide additional protection
against noxious stimuli. All these and other factors prolong
lifespan of stem cells.
In eukaryotes, the chronological cell ageing is checked
through telomere shortening of their chromosomes. The
ends of linear chromosomes are capped with a series of
tandem repeat noncoding TTAGGG sequences that are
protected within a higher order nucleoprotein complex.
These telomeres protect chromosome from end-to-end
fusions, recombination, and degeneration (reviewed in
[13]). However, with each cell division, the most distal
telomere repeats are lost as a result of end-replication
problem. Uncompensated, repeated cell divisions lead to a
criticalshorteningoftelomereswhichinturntriggerscellular
senescence and proliferation arrest [14]. In stem cells, a
speciﬁc ribonucleoprotein enzyme, telomerase, compensates
for telomere shortening (e.g., [15–17]). This enzymatic
activity has been also reported in DPSCs where telomerase
levelswerehigherthaninmesenchymalstemcells[18]which
make DPSCs suitable candidates for ex vivo expansion. A
big advantage of tissue-speciﬁc stem cells over embryonic
stem (ES) cells is their histocompatibility with patient’s
tissues. However, for regenerative transplantation therapies
vast numbers of stem cells are required. Stem cells are rare
cells found in the tissues and as a result, isolation of tissue-
speciﬁc stem cells from a single dental pulp yields 10 to 110
initial cells that adhere and multiplicate [8]. An exponential
increase in stem cell numbers can be reached in relatively
short time when these cells are expanded in vitro with
mitogenic growth factors.
In this paper, we extended DPSC characteristics grown in
cultivation medium with a reduced level of serum. Growth
kinetics characterized by population doublings conﬁrmed
a large proliferative capacity of DPSC lines. Immunophe-
notypisation of DPSCs carried out with ﬂow cytometry
and immunocytochemistry revealed expression of stem cell-
speciﬁc markers. Cultivation of DPSCs in diﬀerentiation
assays gave evidence of their multilineage potential. Finally,
we analyzed relative telomere length in DPSCs at diﬀerent
passages with quantitative real-time PCR and obtained
valuable information on changes that were associated with
long-term cultivation. Although DPSCs remained stable
in their viability, phenotype, and genotype over-prolonged
cultivation, progressive telomere shortening detected by
us indicated that adult tissue-speciﬁc stem cells might be
at risk of detrimental eﬀects caused by excessive ex vivo
expansion.
2.MaterialandMethods
2.1. DPSC Isolation and Cultivation. Impacted third molars
were obtained from healthy donors (impacted third molars:
18–27 years of age, 5 females and 5 males; exfoliated incisor:
8 years, 1 female) at the Department of Dentistry under
approved guidelines of the Ethical Committee of the Faculty
Hospital in Hradec Kr´ alov´ e. Patients or their parents signed
an informed consent statement. The isolation and culture
of DPSCs were performed according to protocol described
Suchanek et al. [19]. Brieﬂy, after the dental pulp was
retrieved, it was dissociated enzymatically with collagenase
type I 3mg/mL (Sevapharma, Czech Republic) and dispase
4mg/mL (Gibco, UK). The harvested cells were splitted
into two dishes: cells in the ﬁrst dish were propagated
to generate maximum cell numbers; these cells underwent
standard passaging procedure including cell counting. The
second dish was used for measurement of CFU-F numbers
in the primary culture (see below). The cells were cultivated
under humidiﬁed 5% CO2 atmosphere at 37◦Ci nb a s i c
expansion medium consisting of alpha-MEM (Gibco, UK)
supplemented with 2% FCS (PAA, USA), 10ng/mL EGF
(PeproTech, USA), 10ng/mL PDGF (PeproTech, USA),
L-ascorbic acid (Sigma, USA), 2% glutamine (Gibco, UK),
penicillin/streptomycin (Gibco, UK), gentamycin (Gibco,
UK), dexamethasone (Sigma, USA), and 10μL/mL ITS
(Sigma).Afterformationofsmallcolonies, thecellsweredis-
sociated with trypsin-EDTA (Gibco, UK) and then reseeded.
Cellswerepassagedeachtimeafterreaching70%conﬂuence.
Cell viability and number of population doublings were
examinedusingVi-CellanalyzerandZ2-Counter(bothfrom
Beckman Coulter, USA). For CFU-F assays, culture medium
was aspirated after 5 days of cultivation, the dish was washed
with phosphate-buﬀer saline (PBS) and adhering cells were
ﬁxed with 3.7% formaldehyde in PBS. CFUs were visualized
with May-Gr¨ unwald, Giemsa-Romanowsky staining. After
washing, all colonies in a dish were counted. Karyotypisation
was carried out in passage p2, p5, and p10 in all cell lines.
The cells were subjected to a 4-hour Demecolcemid (Sigma,
USA) incubation followed by trypsin-EDTA detachment and
lysiswithhypotonic KClandﬁxationinacid/alcohol.Cellsin
metaphasis were analyzed after GTG banding using software
Ikaros v5.0 (MetaSystems, USA).
2.2. Flow Cytometry. For ﬂow cytometric analysis, cells were
detached and stained sequentially with primary antibodies
conjugated with ﬂuorescein or phycoerythrin until analysis
with Cell Lab Quanta (Beckman Coulter, USA). DNA
analysis was performed by DNA Prep kit (Beckman Coulter,
USA) based on propidium iodide staining, according to
manufacturer’s instructions. Percentage of positive cells was
determined as a percentage of cells with higher ﬂuorescence
intensity than the upper 0.5% isotype immunoglobulin
control. Classiﬁcation criteria: <10% no expression, 10%–
40% low expression, 40%–70% moderate expression, and
>70% high expression.
DPSCs were analyzed for CD29 (TS2/16, BioLegend,
USA),CD31(MBC78.2,Invitrogen,USA),CD34(581(Class
III), Invitrogen, USA), CD44 (MEM 85, Invitrogen, USA),
CD45 (HI30, Invitrogen, USA), CD71 (T56/14, Invitrogen,
USA), CD73 (AD2, BD Biosciences Pharmingen, Belgium),
CD90 (F15-42-1-5, Beckman Coulter, USA), CD105 (SN6,
Invitrogen, USA), CD106 (STA, BioLegend, USA), CD146
(TEA1/34, Beckman Coulter, USA), CD166 (3A6, Beckman
Coulter, USA), and HLA I (T¨ u149, Invitrogen, USA).Journal of Biomedicine and Biotechnology 3
2.3. Immunoﬂuorescence. For detection of cytoskeletal pro-
teins, cells were ﬁxed with methanol/acetone at −20◦Cf o r
6 minutes. For detection of other intracellular molecules,
cells were ﬁxed with 4% paraformaldehyde at 20◦Cf o r
10 minutes and permeabilized with 0.1% Triton X-100
for 10 minutes. For identiﬁcation of cell surface antigens,
cells were ﬁxed with 4% paraformaldehyde at 20◦Cf o r
10 minutes. Blocking and diluent solution consisted of
PBS, 5% serum (Sigma) from the same species as was the
primary antibody for 30 minutes. The samples were then
incubated with primary antibody for 90 minutes. Primary
antibodies used in this study were speciﬁc for the following
antigens: CD90 (clone F-15-42-1, 1:100, Acris Antibodies
GmbH, Germany), CD166 (3A6, 1:50, BD Biosciences,
USA), CXCR4 (rabbit polyclonal, 1:100, Acris), nucle-
ostemin (goat polyclonal, 1:10, R&D Systems, USA), nestin
(10C2, 1:200, Chemicon, USA), Sox-2 (rabbit polyclonal,
1:100, Chemicon), STRO-1 (STRO-1, 1:4, DSHB, USA),
and vimentin (V9, 1:40, Sigma). After washing with PBS,
the antigen-binding sites were visualized with secondary
antibody conjugated to ﬂuorochromes. We used incubations
with goat anti-rabbit IgG coupled to Alexa 488 (1:300,
Invitrogen) or goat anti-mouse IgG coupled to Cy3 (1:300,
Jackson Immunoresearch, USA) for 30 minutes. As negative
controls, matching mouse isotype controls were used or
cells were stained with omission of a primary antibody. As
controls, isotype IgG1κ and IgMκ (Abcam, UK) were used.
Cell nuclei were counterstained with DAPI (4 -6-diamidino-
2-phenylindole) (Sigma) for 5 minutes. Coverslips were
mounted in Mowiol or polyvinyl/alcohol/glycerol with 1,4-
diazabicyclo-[2.2.2]-octane (DABCO) as antifading agent.
Samples were examined with BX51 microscope (Olympus)
equipped with DP71 digital camera. The images were
prepared using Adobe Photoshop software.
2.4. Diﬀerentiation Assays. Diﬀerentiation potential of
DPSCs was examined in the passage p2 and p5. Osteogenesis
was triggered by spontaneous aggregation of DPSCs seeded
in osteogenic medium containing alpha-MEM, 0.5mM
ascorbic acid (Sigma), 10mM β-glycerolphosphate (Sigma)
and 0.1μM of dexamethasone (Sigma), and 10% FCS either
in monolayer or in cell pellets. Multilayered osteogenic
nodules and micromass pellets were harvested after 3-4
weeks.
Chondrogenesis was initiated in culture by means of
micromass techniques. Passaged DPSCs were trypsinized
and resuspended in serum-free basal medium supplemented
with 50ng/mL TGF-β1 (Stem Cell Technologies, Canada)
and cultured in 4-mL polypropylene conical tubes (Sarstedt,
Germany) for 2 weeks. The chondrogenic medium was
replenished twice a week.
Adipogenic diﬀerentiation was induced in a monolayer
when DPSCs reached 70% conﬂuence either with medium
containing 10% horse serum (PAA, USA) or with adipogenic
induction medium (α-MEM) (Invitrogen) supplemented
with10%FCS(PAA),1μMdexamethasone(Sigma),0.2mM
indomethacin (Sigma), 0.01mg/mL insulin (Sigma), and
0.5mM 3-isobutyl-l-methyl-xanthine (Sigma). Cultivation
medium was exchanged twice a week. After four weeks,
cultures were ﬁxed with 70% ethanol and stained with oil
red.
2.5. Histology. 3D micromass cultures or osteogenic bodies
harvested from cultures were ﬁxed with 10% formalin,
embedded in paraﬃn, and cut in 7μm sections. After
deparaﬃnisation, the sections were stained with alcian blue
(for 30 minutes in 1% alcian blue solution in 3% acetic
acid), trichrome staining (modiﬁed according to Masson
or Ladewig), or processed for anti-osteonectin immuno-
histochemistry. Prior immunostaining, the sections were
exposed to microwaves (700W) in sodium citrate solution
(2 × 5 minutes) for antigen retrieval. After a thorough
washing with distilled water, endogenous peroxidase activity
was quenched in 3% hydrogen peroxide (3 × 10 minutes).
Following incubation with 5% normal goat serum in PBS for
20 minutes, the sections were treated with anti-osteonectin
antibody (15G12, 1:40, Novocastra, UK) at 4◦C overnight.
After washing, sections were incubated with anti-mouse
EnVision peroxidase kit (Dako, Denmark) according to the
manufacturer’s protocol. Antigen was visualized with DAB
(3,3 -diaminobenzidine tetrahydrochloride, Fluka, Switzer-
land) and intensiﬁed with 3% CuSO4 solution for 5 minutes.
Sections were counterstained with Meyer’s haematoxylin
(Merck,Germany)orlightgreen(BDHChemicalsLtd.,UK),
dehydrated, and mounted in DPX (Fluka).
2.6. Quantitative PCR. Genomic DNA was extracted from
the cells using the silica-gel-membrane-based DNeasy Tissue
Kit (Qiagen, Germany). Telomere length measurement was
performedbytheqPCRassayaccordingtomethoddescribed
by Cawthon [20] with small modiﬁcations. Brieﬂy, the
telomere repeat copy number to single-gene copy number
(T/S) ratio was determined using the equation: T/S = 2−ΔCt
(where ΔCt = Cttelomere –C t single-copy gene). Then, the T/S for
each sample was normalized to T/S value of a reference
DNA sample to standardize between diﬀerent runs, that
is, – ΔΔCt was calculated for each sample. This value is
proportional to the average telomere length of the evaluated
sample. 36B4, encoding acidic ribosomal phosphoprotein
P0, was used as the single copy gene. Telomere and 36B4
gene PCRs were always done in separate 96-well plates with
each sample run in triplicate in the same well position on
an ABI 7500 HT Detection System (Applied Biosystems,
USA). Each 20μL reaction consisted of 20ng DNA, 1 ×
SYBR Green master mix (Applied Biosystems), and 200nM
telomere forward primer (CGG TTT GTT TGG GTT TGG
GTT TGG GTT TGG GTT TGG GTT), 200nM telomere
reverse primer (GGC TTG CCT TAC CCT TAC CCT TAC
CCT TAC CCT TAC CCT). For 36B4gene PCR the following
primer pairs were used: 36B4u, CAG CAA GTG GGA AGG
TGT AAT CC; 36B4d, CCC ATT CTA TCA TCA ACG GGT
ACA A. The DNA quantity standards were derived from
serial dilutions of a reference DNA sample to produce three
ﬁnal concentrations (0.02, 0.2, and 2.0ng/μL). In each run, a
standard curve and a negative control (water) were included.
Cycling conditions (for both telomere and 36B4 products)4 Journal of Biomedicine and Biotechnology
(a) (b)
Figure 1: Phase contrast micrograph of DPSCs in culture. (a) Small colonies (CFU-F) formed by DPSCs appeared in primary culture after
3 days in vitro. (b) Spindle-shaped morphology of cells in culture reaching 70% conﬂuence. Scale bars 50μm.
were 10 minutes at 95◦C, followed by 40 cycles of 95◦C
for 15s and 60◦C for 1 minute. Following ampliﬁcation, a
dissociation curve was done to conﬁrm the speciﬁcity of the
reaction. Standard and dissociation curves were generated
with the ABI Prism 7500 SDS software. R2 for each standard
curve was >0.98.
The Du145 prostate cancer cells were cultured as
described previously [21] and served as a control for
comparison of length of short telomeres with relative T/S
value of DPSCs.
2.7. Statistical Analysis. The relationship between average
telomere length and selected parameters was performed by
correlation analysis using statistic software GraphPad Prism
5.01 (San Diego, USA). A value of P<. 05 was considered
statistically signiﬁcant.
3. Results
3.1. DPSC Kinetics. From each patient, only one tooth was
extracted.Fromthedentalpulpisolatedfromthesingletooth
we established one DPSC line. Although each enzymatic
digestion of the dental pulp yielded only several tens of
adhering cells, after two to three days in vitro (DIV) the
poorly diﬀerentiated cells started to form small colonies.
DPSCs actively migrated, proliferated, and formed new
colonies (Figure 1(a)). By 6-7 DIV, the cells reached 70%
conﬂuence in monolayer and they changed their shape.
The cells elongated, their bodies exhibited ﬁbroblast-like
morphology. Despite their elongated morphology most cells
had ﬂattened and triangular body from which few (usually
three or more) slim cytoplasmic processes emanated. At all
timestheculturecontainedsomeroundeddividingcellswith
more or less retracted processes. All these DPSCs constituted
a homogenous monolayer population (Figure 1(b)).
During passaging, the cell viability, diameter distribu-
tion, and cell numbers were measured. Cells taken from
culture at passages p5–p15 had 15.1 ± 3.4μm in diameter;
p25–p35 cells had averaged size 15.9 ± 4.9μm. Cell kinetics
characterization with cumulative population doublings and
doubling time gave evidence of changes occurring in the
growth rate of DPSC lines during long-term cultivation
(Figure 2) .A l lD P S Cl i n e sw e r ea b l et og r o wb e y o n d
Hayﬂick’s limit. The highest population doubling number
reached in our DPSC lines was 81; after this time point,
the growth of the DPSC line was interrupted for technical
reasons.InitiallyDPSCsshowedincreasedproliferativeactiv-
ity. Doubling time measured in DPSC lines during initial
passages p2–p5 was 23.0 ± 0.8h o u r sa n d2 4 .9 ± 1.4h o u r s
(arithmetic mean ± S.E.M. in males and females, resp.).
Withtheincreasingnumberofpassages,thedoublingtimeof
cultured DPSCs increased as well (Figures 2(b) and 2(c)). At
later passages p16–p20, the cell doubling time slowed down
to 59.9 ± 7.3h o u r sa n d3 9 .1 ± 3.7h o u r si nc e l l sd e r i v e d
from males and females. Interestingly, there were signiﬁcant
diﬀerences in doubling time when comparing values from
p16–p20 between male versus female DPSC lines (P<
.05) while diﬀerence in initial passages were insigniﬁcant
(P = .30). Trypan blue exclusion test demonstrated the
cell viability remained well preserved and did not drop
below 90% in all cell cultures tested. Cytogenetic screening
carried out regularly at distinct passages in all DPSC lines
revealedneitheranychromosomalabnormalitynoranysigns
of degeneration or spontaneous diﬀerentiation.
3.2. Antigenic Proﬁle of DPSCs. Our characterization of
DPSCs included determination of their antigenic proﬁle.
Flow cytometric analysis revealed that the cells did not
express haemopoietic markers CD34 and CD45. Endothelial
cell markers CD31, CD106, and CD146 were also low;
moderate expression was observed in CD105. On the
contrary, DPSCs expressed high levels of mesenchymal
markers CD29, CD44, CD73, CD90, and CD166. Data
received from comparison of phenotypes of cells yielded
from diﬀerent passages were summarized in Figure 3 and
provided evidence of a stable phenotype of DPSC lines.
Moreover, immunoﬂuorescent identiﬁcation (Figures 4(a)–
4(h)) conﬁrmed strong expression of mesenchymal markers
STRO-1 and vimentin in all cultures of DPSCs. STRO-
1 was concentrated on the membrane over the cell body
and large cytoplasmic processes. Protein vimentin was
distributed in the same density in ﬁlamentous network
that entered regularly the body and both ﬂattened andJournal of Biomedicine and Biotechnology 5
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Figure 2: The growth kinetics of DPSC lines. (a) Cumulative population doublings of 11 DPSCs lines are shown. The cultures were derived
from individual patients and passaged as described in Section 2. The number of population doublings was calculated as follows: PD =
(log10nf −log10ni)/0.301, where ni is the initial number of cells and nf is the ﬁnal number of cells at each passage. (b, c) Data of doubling
time reached by DPSCs from male (b) and female (c) donors at diﬀerent passages in culture. The linear regression line best ﬁtting the data
is shown, R = 0.71, P<. 0001. The doubling time was calculated from the formula DT = log102T/log10nf −log10ni,w h e r eT is time in hrs.
R = 0.56, P<. 0001. Filled circles indicate males and open circles indicate females.
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Figure 3:Flowcytometricanalysisofcellsurfacemarkerexpression
in DPSCs at diﬀerent passages. Results are expressed as arithmetic
mean ± SEM.
slim processes. Signal slightly increased around the cell
nucleus.Immunolocalisationofintermediate ﬁlamentnestin
showed variable pattern of expression in DPSCs. In most
cells nestin formed tiny ﬁlamentous network that was
homogenously distributed throughout cell body and con-
centrated around the cell nucleus. However, in smaller
spherical cells that rounded during the mitotic division the
immunoreactivity increased so much that it obscured the
nucleus and cytoplasmic ﬁlaments were not well recogniz-
able. Additionally, we detected several stem cell markers
to be stably expressed in DPSCs. CXCR4 immunostaining
was observed in both a nuclear and cytoplasmic pattern.
A uniform nuclear and faint cytoplasmic staining pattern
was observed in Sox2 immunocytochemistry. Sox2+ signal
in cell cytoplasm was likely associated with rough endo-
plasmic reticulum being localized in the vicinity to the
nucleus and entering the main cytoplasmic processes; signal
intensity increased in dividing cells. Immunodetection of
nucleostemin localised strong signals to several nodular
structures within the nucleus of interphasic cells. Strong
punctate immunolabelling of CD90 was present on the
plasma membrane of all DPSCs. CD166 was localised6 Journal of Biomedicine and Biotechnology
(a) (b)
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(g) (h)
Figure 4: Immunocytochemical detection of analyzed markers in cultured DPSCs. (a) STRO-1 expression was readily detectable in all cells.
(b) Immunostaining of vimentin revealed a regular ﬁlamentous cytoskeletal network within the cells with signal accentuation in perinuclear
region. (c) Nestin expression appeared in the cell body, however, in cytoplasmic outgrowths the signal was lower but still distinguishable.
Intensive signal is localized in dividing cells. (d) CXCR4 was localized mainly in the cytoplasm, namely, in its perinuclear area; some signal
was also distinguishable within the cell nuclei. (e) Sox2 was distributed mainly in cell nuclei; signal in perinuclear cytoplasm likely reﬂects
synthesis of this transcriptionfactor in endoplasmic reticulum. (f)Nucleostemin was observed in nodular structuresin cell nuclei; in mitotic
cells or cells that had just ﬁnished cytokinesis (arrowheads) immunoreactivity was lost from the nucleus and distributed diﬀusely. (g)
CD90 immunoﬂuorescence showed homogenous dot-like membrane staining pattern. (h) CD166 was localised in membrane of all DPSCs
contouring the cell edges. Nuclei were counterstained with DAPI. Arrows indicate dividing cells. Scale bars 50μm.Journal of Biomedicine and Biotechnology 7
(a) (b)
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Figure 5: Osteogenic and chondrogenic potential of DPSCs. (a) Phase contrast micrograph of osteogenic nodule after 4 week-cultivation
in diﬀerentiation medium. (b) Histological examination revealed multilayered structure consisting of osteoblast-like cells surrounded by
extracellular matrix containing collagen ﬁbres; Ladewig blue trichrome. (c) Immunoperoxidase histochemistry of osteonectin conﬁrmed
the presence of this bone-speciﬁc glycoprotein that links minerals to collagen within the micromass pellets. (d) Chondrogenic micromass
bodies were composed of cells and extracellular matrix. Alcian blue staining conﬁrmed the presence of sulphated acidic glycosaminoglycans,
a principal component of cartilaginous ground substance. Scale bars (a)-(b) 100μm, (c) 200μm, (d) and 50μm.
to the cell surface of all DPSCs; the signal was intense
especially in tiny and ﬂattened cell edges tracing well the cell
contours.
Fluorescent co-staining with DAPI conﬁrmed that
DPSCs were mononucleated. Within their cell body the
nucleus was localized eccentrically usually in the pole
opposite to the largest cytoplasmic process. The size of nuclei
slightly varied likely in dependence on the cell cycle phase.
Almost 7% of cells were in G2/M phase, 36% in S phase and
the rest in G1 phase of the cell cycle.
3.3. DPSC Multipotency. To test DPSC multipotency, the
cells were exposed to conditions that initiate osteo-,
chondro-, and adipogenesis. Osteoinductive potential of
DPSCs has been investigated at high density cultures
that resulted in cell aggregation in osteogenic nodules
(Figure 5(a)) or micromass pellets. Histological examination
of both multilayer nodules and osteo-pellets performed
after 3-4 weeks of cultivation revealed that these three-
dimensional structures were formed by osteoblast-like cells
and deposits of extracellular matrix. Basophilic cells that
covered the outer surfaces were smaller than the cells that
were entrapped within the matrix. Histochemical staining
conﬁrmed the presence of collagen ﬁbrils (Figure 5(b))
and osteonectin (Figure 5(c)), two principal bone-related
proteins, within the matrix.
To trigger early chondrogenic diﬀerentiation, we utilized
micromass cell culture technique and exposed aggregated
cells to chondrogenic medium. During two weeks in vitro,
DPSCs in a high density culture system gave rise to three-
dimensional chondrogenic micromass bodies. Cells inside
these bodies retracted their processes, assumed spherical to
oval morphology and started to produce extracellular matrix
(Figure 5(d)). Areas containing the matrix that accumulated
between the cells reached sizes above 40μm. Mostly these
areas remained devoid of the cells although occasionally
the cells became entrapped within the cartilaginous matrix.
Alcian blue staining proved apparent de novo synthesis of
strongly sulphated acidic glycosaminoglycans, a principal
component of cartilaginous ground substance. These alcian
blue-positive areas were surrounded by foci of densely accu-
mulatedchondroblasticcells.Presenceofcellularregionsand
regions ﬁlled with cartilaginous matrix made chondrogenic
micromass bodies less compact than osteogenic pellets. RT
PCR analysis of micromass bodies performed by Karbanova
et al. [22] gave evidence of synthesis of cartilage speciﬁc
collagen II and aggrecan transcripts.8 Journal of Biomedicine and Biotechnology
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DPSCs in a monolayer cultured under conditions sup-
porting adipogenesis continued to proliferate and grow
in few layers. However, despite diﬀerent adipogenic assays
tested, we neither observed formation of vacuoles nor
accumulation of lipid droplets in the cell cytoplasm in any
DPSC line.
3.4. Telomere Length Measurement in DPSCs. In order to
analyze the eﬀect of serial passages on relative telomere
length in DPSC lines, we extracted DNA from DPSC lines
harvested at diﬀerent passages from culture and processed
them using quantitative real-time PCR. In each plate,
a standard curve was generated from a reference DNA
sample serially diluted by dilution factor 2 to produce six
concentrations of DNA ranging from 0.625 to 20ng of DNA
per reaction (Figure 6). The R2 for each standard curve was
>0.98. Relative T/S ratio was calculated in DNA samples
from cultured cells by correction of T/S ratio detected in
evaluated sample by the T/S value of reference sample.
For comparison of T/S values with telomere length we
processed DNA from human prostate cancer Du145 cells.
This adenocarcinoma cell line has been reported to have a
short mean telomere length of 2.8kb [21] and this average
telomerelengthremainedstablethroughoutpassages[23].In
our assayfor telomere length measurement,relative T/S ratio
in Du145 cells was equal to 0.13. This value was more than
twice lower than values measured in any DPSC line from late
passages.
DPSCs included in this analysis were harvested from
passages p2 to p16, that is, they reached 16 to 50 popula-
tion doublings. DPSC lines derived from diﬀerent patients
showed values of relative T/S which were within the interval
0.3 to 1.33. Despite this interindividual variation among
patients the trend in the change of relative T/S ratio over
passages in time was apparent; DPSC lines showed an overall
and signiﬁcant decrease in relative telomere length with
increasing passage number (P<. 0001) (Figure 7(a)). Also
changes in doubling time versus relative telomere length
(T/S) were signiﬁcant (P<. 05) which demonstrated
prolongation of doubling time in cells with shortened
telomerelength(Figure 7(b)).Duetolownumberofsamples
taken from patients of the same age group, we were not able
toanalyzeage-relatedshorteninginDPSCtelomerelengthor
dependence of telomere length on gender.
4. Discussion
In this study, we provide the DPSC characteristics grown
in optimal conditions with a reduced level of serum. Our
results demonstrate that under these in vitro conditions
DPSC lines are capable of long-term cultivation without
changing their viability, phenotype, and genotype. DPSCs
express many stem cells markers in distinct pattern from
other adult stem cells. We report here that DPSCs do not
express haemopoietic marker CD34 and CD45. On the
other hand they express at high levels mesenchymal markers
such as vimentin, STRO-1, CD29, CD44, CD73, CD90, and
CD166 and thus DPSCs are related to mesenchymal stem
cells isolated from the bone marrow although they diﬀer in
some other markers. Expression of pluripotent embryonic
stemcellmarkerSox-2conﬁrmsaprimitivenatureofDPSCs.
Neural stem cell markers such as nestin and nucleostemin
observed by us in DPSCs may reﬂect the neural crest origin
ofthedentalpulp.DPSCshavebeenalsodescribedtoexpress
astroglial marker GFAP [24]. We also described distribution
of the selected markers within DPSCs as well as changes in
their expression during the cell cycle.
Another feature of adult stem cells is their multilineage
potential. DPSCs have a potential to create a dental-pulp
complex after transplantation into immunocompromised
mice and in vitro they exhibit ability to produce mineralized
bony tissues [24, 25]. Since dental tissues are very speciﬁc
structures that could be generated only in in vivo assays,
we restricted identiﬁcation of stem cell multipotency to in
vitro assays utilized in the study of mesenchymal stem cells.
Our data demonstrated a clear osteogenic and chondrogenic
potential of DPSCs. On the other hand, we were not able
to trigger adipogenesis from DPSCs. Nevertheless these
ﬁndings are in agreement with observation of Gronthos
et al. [7] who expanded DPSCs from single cell clones and
demonstrated their osteogenic properties and no formation
of lipid laden adipocytes. In their later study Gronthos
et al. [24] reported DPSCs were able to generate adipocytes
albeit unwillingly. In this study, we also documented DPSCs
had chondrogenic potential. Such potential for osteo-,
chondro-, and adipogenesis may seem to be surprising
because these tissues are not resident components of the
dental pulp cavity or its surrounding tissues. Nevertheless
osteo- and chondro-genic repertoire may be explained by
ectomesenchymal origin of the dental pulp. The neural
crest contributes to building head skeleton, for example,
face bones and membranous bones of the skull vault, to
visceral cartilages as reviewed by Santagati and Rijli [26]
and also to subsets of adipocytes, namely, in the ear regionJournal of Biomedicine and Biotechnology 9
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Figure 7: Plot of average telomere length (relative T/S) against passage number and doubling time versus T/S. (a) Relative telomere length
expressedasratioofT/Sbyquantitativereal-timePCRanalysisshowsadecreaseinT/Swithincreasingpassagenumbers.(b)Plotofdoubling
time in hours against relative telomere length (T/S) and regression line. The correlation coeﬃcients of the linear regression line best ﬁtting
the data are shown. Filled circles indicate males (n = 5 individuals) and open circles indicate females (n = 6).
[27]. Similarly to the neural crest stem cells which have
broader diﬀerentiation potential, DPSCs show in distinct
diﬀerentiation regimes, potential to generate multiple cell
types including neural, glial, endothelial, and smooth muscle
cells (see [22], unpublished results).
In addition to expression of stem cell markers by
DPSCs and proof of their multipotency, we documented
their extensive proliferative capacity in long-term culture.
On the contrary to somatic cells, the stem cells may
be propagated over Hayﬂick’s limit. Replicative capacity
in somatic cells is restricted due to a steady decline in
telomere length with each round of DNA replication [28]
that ultimately stops cell division and causes senescence.
The stem cells gained an advantage over somatic cells and
evolved mechanisms that could counteract telomere loss;
they express a speciﬁc ribonucleoprotein enzyme, telom-
erase, which is required for telomere length maintenance.
As a result functional stem cells could be isolated from
tissues of elderly people [29] where these cells still perform
their vital functions associated with tissue maintenance
and regeneration. Serial transplantation experiments with
mouse haemopoietic stem cells gave evidence that func-
tional capacity of stem cells exceeds beyond lifespan of
the organism since the stem cells may be successfully
transplanted in several rounds [15]. Observations that, for
example, embryonic stem cells can be propagated in vitro for
decades and remain stable led to speculations on stem cell
immortality.
When monitoring parameters related to cell kinetics
in time we noticed some characteristic changes in human
DPSCs that could be summarized as a decrease of their
proliferation rate during long-term cell cultivation and
increase of their doubling time. Similar ﬁndings were also
published by Huang et al. [9] who reported rhesus DPSCs
had a high proliferation rate during early passages from
establishment of the cells lines which decreased gradually
during cultivation. Interestingly, we observed that doubling
time of cell lines derived from males showed signiﬁcantly
larger prolongation when compared with data taken from
female DPSC lines. Such observation may reﬂect a larger
resistance of female stem cells described, for example, by
Crisostomo et al. [30], a longer life expectancy of females
or exposure of a source tissue to estrogen, which can
upregulatetelomerase[31].Nevertheless,theoverallincrease
in doubling time indicates stem cell ageing that is linked with
a decrease of their regenerative capacity and with ageing of
tissues.
In order to explain if the above mentioned changes
in DPSC kinetics are related to telomere shortening, we
analyzed telomere length in cells harvested from culture at
diﬀerent passages. We utilized quantitative real-time PCR
assay that allows the rapid measurement of the telomere-to-
single copy gene (T/S) ratio, which has been demonstrated
to be proportional to the average telomere length [20].
Results obtained with quantitative PCR are comparable
with other quantitative methods, such as ﬂow-FISH and
Southern blotting [32]. Our data provided a clear evidence
of telomere shortening which was detected by us when
comparing relative telomere length of DPSCs harvested at
diﬀerent time intervals from culture. We also demonstrated
that a decrease in relative T/S in time was associated with
slowingdowndoublingtimeofDPSCs.Wemeasuredrelative
telomere length in cells obtained from passages p2 to p16
which spanned approximately 2 months in vitro during
which cells extensively duplicated. By passage 16 the cells
reached in average 40 population doublings which indicated
a1 0 12-increase in cell number. Such remarkable ex vivo
expansion on the one hand might be useful for obtention of10 Journal of Biomedicine and Biotechnology
large numbers of desired stem cells necessary for treatment
of patients by cell transplantation but on the other hand
might be associated with stressful conditions that lead to
a decrease of replicative capacity or ultimately to stem cell
exhaustion.
It is believed that telomerase activity is responsible for
at least partial restoration of telomere DNA strands. Inter-
estingly the levels of telomerase activity may diﬀer among
stem cell populations which likely reﬂect their diﬀerent hier-
archical origin. Embryonic stem cells have high telomerase
activitywhichmakesthemvirtuallyimmortal[17].Although
telomerase has been described in distinct populations of
adult tissue-speciﬁc stem cells incl. haemopoietic [15, 33],
liver [34], epidermal [16], intestinal [35], and neural [36],
this activity is insuﬃcient to completely prevent telomere
loss. This might be the case of DPSCs too. Sonoyama et al.
[18] detected telomerase activity in human DPSCs isolated
from the ﬁrst three passages that was larger than activity of
bone marrow stromal stem cells. However, the authors nei-
ther determined telomere dynamics nor telomerase activity
at later passages.
5. Conclusions
In conclusion, we conﬁrmed that extensive in vitro prolifera-
tion of human DPSCs was associated with telomere attrition
which signiﬁcantly correlated with prolongation of DPSC
doubling time. These ﬁndings cover several relevant aspects.
First, can the ratio of telomere shortening in stem cells be
attenuatedbylessstressfulinvitroconditions?Chronicstress
andoxygen radicals accelerateloss oftelomeres and diminish
the individual’s lifespan [37]. Second, a progressive telomere
shortening diminishes transplantation capacity of stem cells
making them less suitable for therapeutic applications. If
ex vivo expansion causes shrinkage of telomeres in tissue-
speciﬁc stem cells other alternative procedures allowing large
yields of stem cells should be preferred. By introducing genes
encoding pluripotent transcription factors into ﬁbroblasts,
Takahashi and Yamanaka [38] laid basis for generation of
induced pluripotent stem cells. Despite the advantage that
such cells may be isolated from somatic cells of old patients,
their reprogramming is associated with full re-elongation
of telomeres to sizes comparable with early embryonic cells
[17]. Finally, determination of telomere length represents
an important biomarker that should be taken into consid-
eration when characterizing the status and replicative age
of stem cells prior their utilization in treatment of human
patients.
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